APA (7th ed.) Citation

LT, W., WC, C., KS, M., CH, C., YC, C., WC, T., & BH, Y. (2025). Association of hydralazine use with risk of hematologic neoplasms in patients with hypertension: A nationwide population-based cohort study in Taiwan. PLoS medicine, 22(12), e1004646. https://doi.org/10.1371/journal.pmed.1004646

Chicago Style (17th ed.) Citation

LT, Wang, Chien WC, Ma KS, Chung CH, Chen YC, Tsai WC, and Yang BH. "Association of Hydralazine Use with Risk of Hematologic Neoplasms in Patients with Hypertension: A Nationwide Population-based Cohort Study in Taiwan." PLoS Medicine 22, no. 12 (2025): e1004646. https://doi.org/10.1371/journal.pmed.1004646.

MLA (9th ed.) Citation

LT, Wang, et al. "Association of Hydralazine Use with Risk of Hematologic Neoplasms in Patients with Hypertension: A Nationwide Population-based Cohort Study in Taiwan." PLoS Medicine, vol. 22, no. 12, 2025, p. e1004646, https://doi.org/10.1371/journal.pmed.1004646.